- About Ilko
- Product Portfolio
- Human Resources
- Press Room
İLKO Pharmaceuticals aims at using 'innovative' products that extent the lifetime and save lives, and create a difference in the production of pharmaceuticals, thus adding value to the industry. İLKO ARGEM, the R&D center that we established at Hacettepe University Teknokent, is one of the steps we took by considering the future. İLKO ARGEM, with an area of 2.600 sqm, consists of two units as analytic and galenic laboratories. It develops specific products based on advanced technology in R&D studies conducted with a specialized team and superior laboratory equipment.
In addition, İLKO İLaç continues its biotechnological products-related studies at İLKO ARGEM Biotechnological Research and Development Center, which was established last year. The center, which is the first biotechnological R&D center in Turkey, conducts studies related to the development of biotechnological medicines, using the recombinant DNA technology. İLKO Argem Biotechnology Center was built with an infrastructure that enables the production of biosimilar, biosuperior, and next generation medicines.
İLKO Pharmaceuticals, with the required infrastructure to conduct studies directed to all major treatment areas, has conducted studies in the field of the nerve system, digestion system, respiratory system, metabolism, cardiovascular system, musculoskeletal system, dermatology, immunology, endocrinology and infection diseases. İLKO ARGEM Biotechnology Center conducts studies in order to develop biotechnological products against cancer and cancer-related diseases at the first stage.
İLKO Argem creates an infrastructure within the university-industry cooperation on R&D and it is a leading and exemplary R&D investment within Teknokent at this scale.